Related Experiment Videos
Quetiapine monotherapy for bipolar depression
Philip G Janicak1, Jeffrey T Rado
1Psychiatric Clinical Research Center, Rush University, 2150 West Harrison Street, Suite 253, Chicago, IL 60612, USA. pjanicak@rush.edu
Expert Opinion on Pharmacotherapy
|May 26, 2011
Summary
Quetiapine is the only approved monotherapy for bipolar disorder, treating mania, depression, and maintenance. Its antipsychotic properties offer broad mood stabilization, simplifying management for some patients.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Bipolar depression is more common and disabling than mania/hypomania.
- Treating bipolar depression is complex, with limited evidence for pharmacotherapy.
- Bipolar depression poses significant management challenges.
Purpose of the Study:
- To review quetiapine's mechanism of action and pharmacokinetics.
- To assess the evidence base for quetiapine in bipolar depression.
- To examine quetiapine's safety and tolerability profile.
Main Methods:
- Literature review of quetiapine's properties and clinical trials.
- Analysis of pharmacokinetic and pharmacodynamic data.
- Evaluation of safety and tolerability studies.
Main Results:
- Quetiapine is the sole monotherapy approved for bipolar mania, depression, and maintenance.
- Evidence supports quetiapine's efficacy across different bipolar phases.
- Quetiapine demonstrates a manageable safety and tolerability profile.
Conclusions:
- Quetiapine offers a unique broad mood-stabilizing potential beyond antipsychotic effects.
- This broad efficacy may simplify treatment algorithms for bipolar disorder.
- Quetiapine can benefit select bipolar patients who tolerate the medication.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...